- SID Score
- 6.2/10
- Fair value
- $185.72
- Generated
- Sep 18, 2026
- Model
- claude-haiku-4-5-20251001
International Business Machines Corporation trades at $237.75 with a market capitalization of $290.3 billion, currently yielding a modest 0.02% dividend. The stock carries a P/E ratio of 36.68, which appears elevated relative to the estimated fair value of $185.72, suggesting a potential 23.7% downside from current levels. The SID Score of 6.2/10 indicates moderate investment attractiveness, with mixed factor grades reflecting both strengths and significant weaknesses across key metrics.
IBM's valuation metrics reveal concerning disparities between current price and intrinsic value, with the stock trading at a significant premium to fair value estimates. The Value factor receives an F grade while Growth also scores F, indicating the company lacks both deep discount pricing and robust expansion prospects. However, recent earnings have shown mixed performance with Q1 2026 beating estimates ($2.93 vs $3.02 expected) and strong sequential results in January ($4.52 vs $4.31 estimated), suggesting operational execution challenges relative to expectations. The Profitability grade of C and minimal 0.02% dividend yield further highlight IBM's struggle to generate sufficient returns for shareholders despite its substantial market capitalization.
The stock's 50-day moving average of $234.79 sits slightly below the current price of $237.75, indicating minimal recent upward momentum, while the 200-day moving average of $253.98 reveals the stock has declined approximately 6.4% over the longer term. The RSI(14) reading of 56.0 suggests the stock is neither overbought nor oversold, positioning it in neutral territory with room to move in either direction. This technical positioning, combined with a B-rated Momentum factor, suggests the stock may lack the conviction for sustained directional movement in either direction.
Analyst & Insider Sentiment
Analyst consensus remains constructively "Buy" with an average price target of $293.86, implying approximately 23.6% upside from current levels, which contrasts sharply with the fair value estimate of $185.72. Recent insider activity presents a mixed signal, with Krishna Arvind's purchase of 8,376 shares on August 27, 2026 suggesting confidence from at least one executive, offset by significant selling activity from Thomas Robert David (25,000 shares on August 26) and Anne Robinson (22,356 combined shares in early July). The divergence between analyst targets and fair value estimates raises questions about the reliability of consensus projections for this particular security.
IBM faces substantial valuation risk given the 23.7% gap between current price and estimated fair value, representing significant downside exposure if market sentiment deteriorates or growth expectations reset. The poor Value and Growth grades combined with modest Profitability metrics (C rating) suggest limited margin of safety, while the company operates in a highly competitive technology sector vulnerable to disruption and rapid obsolescence. Insider selling by senior executives, particularly the substantial 25,000-share position reduction, may indicate management concerns about current valuation levels or company direction.
IBM represents a conflicted investment case where analyst consensus and positive momentum indicators clash with fundamental valuation concerns and weak growth prospects. While the B-rated Momentum factor and recent earnings beats provide short-term tactical support, the F-rated Value and Growth factors combined with 23.7% downside to fair value suggest limited margin of safety for new investors at current prices. The most prudent approach involves waiting for either a meaningful price decline toward the $185 fair value range or compelling evidence of sustainable growth acceleration before establishing a meaningful position in this mature technology conglomerate.
